Positive Efficacy Data in Murdoch Children’s Research Institute Urinary Tract Infection Animal Study
Highlights:
Murdoch Children’s Research Institutedata shows significant RECCE®327 (R327)
bactericidal activity againstEscherichia coliUrinary Tract Infections (UTI) in rat
model via intravenous infusion and new direct-to-bladder delivery
R327 is currently undergoing a Phase I/II UTI/Urosepsis Rapid Infusion Clinical
Trial to address needs at first patient presentation in GP and hospital settings
In 2019, >404.6m individualshad UTI’sglobally, ~80% resistant to two or more
antibiotics
Results of UTI study support potential for present Phase I/II Clinical Trial
Good results coming for patients - great to see
Positive Efficacy Data in Murdoch Children’s Research Institute...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
-0.015(2.86%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 50.5¢ | $40.89K | 79.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 677 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 392 | 1 |
View Market Depth
| Last trade - 15.59pm 13/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |